Bill
Bill > A3655
NJ A3655
NJ A3655Extends "Epinephrine Access and Emergency Treatment Act" to include administration of epinephrine auto-injector devices by individuals in possession of devices pursuant to personal prescriptions.
summary
Introduced
01/13/2026
01/13/2026
In Committee
01/13/2026
01/13/2026
Crossed Over
Passed
Dead
Introduced Session
2026-2027 Regular Session
Bill Summary
This bill revises the provisions of the "Epinephrine Access and Emergency Treatment Act" to allow any person who is in possession of an epinephrine auto-injector device pursuant to a valid prescription that was issued to the person, or to a minor child of the person, to administer the auto-injector device to any individual who appears to be suffering from anaphylaxis or any other serious condition that is treatable with epinephrine. The person would not be subject to civil liability for administering the device in good faith and without fee. Currently, the "Epinephrine Access and Emergency Treatment Act" permits any person to obtain, administer, maintain, and dispose of epinephrine auto-injector devices upon completing an educational program approved by the Commissioner of Health. However, current law does not explicitly allow individuals in possession of a device pursuant to a prescription issued to that person or a minor child of the person to administer the device to another individual in an emergency. It is the sponsor's belief that extending the scope of the "Epinephrine Access and Emergency Treatment Act" in this way will help promote access to this life-saving medication and encourage individuals in possession of the devices to administer them in emergency situations.
AI Summary
This bill expands the "Epinephrine Access and Emergency Treatment Act" to allow individuals who possess an epinephrine auto-injector device, prescribed to them or their minor child, to administer it to someone experiencing anaphylaxis or another serious condition treatable with epinephrine, even if that person is not the patient for whom the prescription was written. Anaphylaxis is a severe, potentially life-threatening allergic reaction. The bill clarifies that these individuals, acting in good faith and without charge, will be protected from civil liability for administering the device, thereby aiming to increase access to this life-saving medication in emergencies.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Introduced, Referred to Assembly Health Committee (on 01/13/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2026/A3655 |
| BillText | https://pub.njleg.gov/Bills/2026/A4000/3655_I1.HTM |
Loading...